by no means an expert, however, the difference between an implantable device (and being a replacement heart valve, and therefore vital for survival) and a drug that can be stopped is one factor that may drive the amount of evidence required, and, having a performance level to be achieved (XX% better improvement), there will likely be a complicated calculation that will determine the necessary sample size for the trial.
Just a relatively uneducated opinion - not advice.
- Forums
- ASX - By Stock
- Ann: Update on Pivotal Trial Submission
by no means an expert, however, the difference between an...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.80 |
Change
0.000(0.00%) |
Mkt cap ! $249.4M |
Open | High | Low | Value | Volume |
$11.80 | $11.85 | $11.60 | $44.76K | 3.801K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16 | $11.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.11 | 639 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16 | 11.610 |
1 | 80 | 11.600 |
1 | 500 | 11.510 |
2 | 1425 | 11.500 |
1 | 80 | 11.250 |
Price($) | Vol. | No. |
---|---|---|
12.110 | 639 | 2 |
12.120 | 511 | 2 |
12.130 | 160 | 1 |
12.140 | 160 | 1 |
12.150 | 849 | 1 |
Last trade - 10.42am 04/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |